← Back to all trials
Recruiting
NCT04258488
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
Conditions: AORTIC VALVE DISEASES, Thromboembolism
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 1300
Sponsor: Joon Bum Kim
Location: Buchen Sejong Hospital Bucheon-si
Summary
This study evaluates the long-term anticoagulation with oral factor Xa inhibitor versus vitamin K antagonist in patients receiving a mechanical aortic valve replacement.
Eligibility Criteria
Inclusion Criteria:
1. Age 19 and more
2. At least 3 months after mechanical aortic valve replacement
3. At least one of the conditions(as defined below) is met
* The New York Heart Association (NYHA) Functional Classification I or II; or
* According to the Valve Academic Research Consortium(VARC)2 criteria, confirmed proper valve function: no prosthesis-patient mismatch and mean aortic valve gradient \
Source: ClinicalTrials.gov (NCT04258488). StuddyBuddy aggregates publicly available trial information.
